Dr June Raine DBE
Dr Raine qualified in medicine at Oxford University, and undertook postgraduate research leading to an MSc in pharmacology.
After general medical posts and Membership of the Royal Colleges of Physicians (MRCP), she joined the then Medicines Division in 1985, and has worked in several licensing areas, including the Review of Medicines, new drugs and abridged. Prior to becoming Chief Executive, June was Director of Vigilance and Risk Management of Medicines from 1999 to 2019.
As Chief Executive, June chairs the Executive Committee, which is the highest decision-making body in the agency. Dr Raine was made a DBE in the New Year Honours List 2022 for services to healthcare and the Covid-19 response.